ArticleScientific reports2025

Pretreatment PET dissemination features as biomarkers for survival outcomes in melanoma patients treated with immune-checkpoint inhibitors.

Hanna Saadani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.